{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T22:55:21Z","timestamp":1773442521956,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ijrobp.2019.12.036","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T21:46:49Z","timestamp":1579902409000},"page":"968-976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Outcomes Following Proton Therapy for Group III Pelvic Rhabdomyosarcoma"],"prefix":"10.1016","volume":"106","author":[{"given":"Daniel J.","family":"Indelicato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronny L.","family":"Rotondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Krasin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond B.","family":"Mailhot Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Uezono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Bradfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibhuti","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie A.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2019.12.036_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.radonc.2014.08.033","article-title":"A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study","volume":"113","author":"Ladra","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib2","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ijrobp.2010.07.1989","article-title":"Proton radiotherapy for pediatric bladder\/prostate rhabdomyosarcoma: Clinical outcomes and dosimetry compared to intensity modulated radiation therapy","volume":"81","author":"Cotter","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib3","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/cncr.27934","article-title":"Radiation therapy target volume reduction in pediatric rhabdomyosarcoma: Implications for patterns of disease recurrence and overall survival","volume":"119","author":"Eaton","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijrobp.2015.01.049","article-title":"Local failure in parameningeal rhabdomyosarcoma correlates with poor response to induction chemotherapy","volume":"92","author":"Ladra","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1200\/JCO.1995.13.3.610","article-title":"The Third Intergroup Rhabdomyosarcoma Study","volume":"13","author":"Crist","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/pbc.24727","article-title":"Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: Results from International Society of Paediatric Oncology (SIOP) studies: Malignant mesenchymal tumour (MMT) 84, 89 and 95","volume":"61","author":"Jenney","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib7","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/pbc.22950","article-title":"Treatment efficiency, outcome and surgical treatment problems in patients suffering from localized embryonal bladder\/prostate rhabdomyosarcoma: A report from the Cooperative Soft Tissue Sarcoma trial CWS-96","volume":"56","author":"Seitz","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib8","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/pbc.20012","article-title":"Results of treatment of fifty-six patients with localized retroperitoneal and pelvic rhabdomyosarcoma: A report from The Intergroup Rhabdomyosarcoma Study-IV, 1991-1997","volume":"42","author":"Raney","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib9","first-page":"467","article-title":"Advances in ventriculography and myelography with the non-ionic constrast medium metrizamide","volume":"347","author":"Gonsette","year":"1976","journal-title":"Acta Radiol Suppl"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib10","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1245\/s10434-016-5391-0","article-title":"Improvements in the treatment of patients suffering from bladder-prostate rhabdomyosarcoma: A report from the CWS-2002P trial","volume":"23","author":"Seitz","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib11","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/1097-0142(19930401)71:7<2387::AID-CNCR2820710734>3.0.CO;2-A","article-title":"Sequelae of treatment in 109 patients followed for 5 to 15 years after diagnosis of sarcoma of the bladder and prostate. A report from the Intergroup Rhabdomyosarcoma Study Committee","volume":"71","author":"Raney","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib12","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/bjc.1994.437","article-title":"Bladder and kidney function after cure of pelvic rhabdomyosarcoma in childhood","volume":"70","author":"Yeung","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1464-410X.2004.04570.x","article-title":"Rhabdomyosarcoma of the bladder,\u00a0prostate or vagina: The role of surgery","volume":"93","author":"Filipas","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib14","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/pbc.24087","article-title":"What is the evidence for radical surgery in the management of localized embryonal bladder\/prostate rhabdomyosarcoma?","volume":"58","author":"Alexander","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/1756287218759883","article-title":"Appraisal of the role of radical prostatectomy for rhabdomyosarcoma in children: Oncological and urological outcome","volume":"10","author":"Angelini","year":"2018","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11934-018-0761-8","article-title":"Current treatment of pediatric bladder and prostate rhabdomyosarcoma","volume":"19","author":"Saltzman","year":"2018","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib17","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s11255-016-1285-0","article-title":"Focusing on organ preservation and function: Paradigm shifts in the treatment of pediatric genitourinary rhabdomyosarcoma","volume":"48","author":"Shapiro","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/MOU.0000000000000651","article-title":"Current treatment of pediatric bladder and prostate rhabdomyosarcoma (bladder preserving vs. radical cystectomy)","volume":"29","author":"Castagnetti","year":"2019","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib19","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.ijrobp.2015.08.040","article-title":"Local control for intermediate-risk rhabdomyosarcoma: Results from D9803 according to histology, group, site, and size: A report from the Children's Oncology Group","volume":"93","author":"Wolden","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib20","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ijrobp.2017.02.026","article-title":"Brachytherapy combined with surgery for conservative treatment of children with bladder neck and\/or prostate rhabdomyosarcoma","volume":"98","author":"Chargari","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib21","doi-asserted-by":"crossref","first-page":"e27952","DOI":"10.1002\/pbc.27952","article-title":"Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma","author":"Buszek","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib22","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1200\/JCO.2005.12.096","article-title":"Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors","volume":"23","author":"Spunt","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.juro.2013.08.007","article-title":"Risk factors and predictors of severity score and complications of pediatric hemorrhagic cystitis","volume":"191","author":"Riachy","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib24","doi-asserted-by":"crossref","first-page":"404.e401","DOI":"10.1016\/j.jpurol.2016.07.002","article-title":"Erectile function after treatment for rhabdomyosarcoma of prostate and bladder","volume":"12","author":"Frees","year":"2016","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00066-011-2261-3","article-title":"Comparison\u00a0of\u00a0different adjuvant radiotherapy approaches in childhood bladder\/prostate rhabdomyosarcoma treated with conservative surgery","volume":"187","author":"Heinzelmann","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib26","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1200\/JCO.2019.37.15_suppl.1503","article-title":"Risk of subsequent cancer diagnosis in patients treated with 3D conformal, intensity modulated, or proton beam radiation therapy","volume":"37","author":"Xiang","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib27","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1002\/cncr.32204","article-title":"Increased local failure for patients with intermediate-risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology Group","volume":"125","author":"Casey","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/annonc\/mdt426","article-title":"Parameningeal rhabdomyosarcoma in pediatric age: Results of a pooled analysis from North American and European cooperative groups","volume":"25","author":"Merks","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib29","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1200\/JCO.2005.05.3801","article-title":"Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group","volume":"24","author":"Meza","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijrobp.2018.08.017","article-title":"Treatment approach and outcomes in infants with localized rhabdomyosarcoma: A report from the soft tissue sarcoma committee of the Children's Oncology Group","volume":"103","author":"Bradley","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib31","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1097\/01.ju.0000127752.41749.a4","article-title":"Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder\/prostate rhabdomyosarcoma? Results from Intergroup Rhabdomyosarcoma Study IV","volume":"171","author":"Arndt","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib32","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.juro.2006.07.064","article-title":"Late effects in 164 patients with rhabdomyosarcoma of the bladder\/prostate region: A report from the international workshop","volume":"176","author":"Raney","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib33","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1200\/JCO.2008.19.5933","article-title":"Prognostic significance of tumor response at the end of therapy in group III rhabdomyosarcoma: A report from the children's oncology group","volume":"27","author":"Rodeberg","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.12.036_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/01.mph.0000212978.21372.97","article-title":"Significance of persistent mature rhabdomyoblasts in bladder\/prostate rhabdomyosarcoma: Results from IRS IV","volume":"28","author":"Arndt","year":"2006","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620300110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620300110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:47:04Z","timestamp":1759744024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301620300110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0360301620300110"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2019.12.036","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes Following Proton Therapy for Group III Pelvic Rhabdomyosarcoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2019.12.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}